Dermatologists warn against injecting GHK-Cu copper peptide bought online
Human trials of GHK-Cu have covered topical use in skin and hair only; the injectable route has no published human safety or efficacy data.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 8 03:00 ETSource: Medical Daily
The wire
- 01Medical Daily reports dermatologists and longevity researchers urging patients to avoid subcutaneous GHK-Cu, citing copper overload and immune reaction risks flagged in NPR reporting.
- 02Patients are buying unregulated vials online and self-injecting, often stacked with other repair peptides, with no way to verify contents, dose or sterility.
- 03University of Washington researcher Warren Ladiges says GHK-Cu occurs naturally in the body, making it hard to patent, and expects federal approval is probably never coming.
From the source
Read at medicaldaily.comDoctors Are Telling Patients to Hold Off on Copper Peptide Injections Until Human Safety Studies Exist
Dermatologists and longevity researchers are urging patients to stop short of injecting copper peptides, a compound that has moved from face serums to home syringes without a single published human study showing the injectable form is safe or effective.